ENTO – entero therapeutics inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ENTO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

10/14

12:13 pm

ento

Entero Therapeutics (NASDAQ:ENTO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Medium Report

Entero Therapeutics (NASDAQ:ENTO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Report

10/4

12:05 am

ento

Entero Therapeutics (NASDAQ:ENTO) was upgraded by analysts at Wall Stree

Low Report

Entero Therapeutics (NASDAQ:ENTO) was upgraded by analysts at Wall Stree

Report

10/3

03:35 pm

ento

Entero Therapeutics (NASDAQ:ENTO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Low Report

Entero Therapeutics (NASDAQ:ENTO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Report

9/18

05:40 pm

ento

NF-?B Inhibitors Market to Witness Accelerated Expansion Across the 7MM through 2034 | DelveInsight [Yahoo! Finance]

High Report

NF-?B Inhibitors Market to Witness Accelerated Expansion Across the 7MM through 2034 | DelveInsight [Yahoo! Finance]

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.